Article info
PDFWhat neurologists need to understand outside their own speciality
Ammonia: what adult neurologists need to know
- Correspondence to Elaine Murphy, Consultant Adult Inherited Metabolic Disease, Charles Dent Metabolic Unit, Internal Mailbox 92, National Hospital for Neurology and Neurosurgery, Queen Square, London, UK; elaine.murphy8{at}nhs.net
Citation
Ammonia: what adult neurologists need to know
Publication history
- Accepted August 4, 2020
- First published December 11, 2020.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- How to use serum ammonia
- Recurrent vomiting and lethargy in an infant—just another viral illness?
- Hyperammonaemic encephalopathy after initiation of valproate therapy in unrecognised ornithine transcarbamylase deficiency
- Status epilepticus secondary to hyperammonaemia: a late presentation of an undiagnosed urea cycle defect
- Drug-induced hyperammonaemia
- Prenatal benzoate treatment in urea cycle defects
- Valproate-induced fatal acute hyperammonaemia-related encephalopathy in late-onset ornithine transcarbamylase deficiency
- Non-hepatic hyperammonaemia: an important, potentially reversible cause of encephalopathy
- Ornithine carbamoyltransferase deficiency
- Late-onset ornithine transcarbamylase deficiency mimicking a focal opercular syndrome